Drug Approval Package
ZANTAC INJECTION (RANITIDINE HYDROCHLORIDE)
Company: Glaxo Wellcome Inc.
Application No.: 019090, S37
Approval Date: 10/29/1999
-
Approval Letter(s) (PDF)
-
Clinical Pharmacology Biopharmaceutics Review(s) (PDF)
Part 1 (PDF)
Part 2 (PDF)